← Back to Research Radar
Academic Publication Academic Publication

Liver diseases: epidemiology, causes, trends and predictions

199
Citations
February 5, 2025
Published Date

Research Abstract & Technology Focus

Abstract
As a highly complex organ with digestive, endocrine, and immune-regulatory functions, the liver is pivotal in maintaining physiological homeostasis through its roles in metabolism, detoxification, and immune response. Various factors including viruses, alcohol, metabolites, toxins, and other pathogenic agents can compromise liver function, leading to acute or chronic injury that may progress to end-stage liver diseases. While sharing common features, liver diseases exhibit distinct pathophysiological, clinical, and therapeutic profiles. Currently, liver diseases contribute to approximately 2 million deaths globally each year, imposing significant economic and social burdens worldwide. However, there is no cure for many kinds of liver diseases, partly due to a lack of thorough understanding of the development of these liver diseases. Therefore, this review provides a comprehensive examination of the epidemiology and characteristics of liver diseases, covering a spectrum from acute and chronic conditions to end-stage manifestations. We also highlight the multifaceted mechanisms underlying the initiation and progression of liver diseases, spanning molecular and cellular levels to organ networks. Additionally, this review offers updates on innovative diagnostic techniques, current treatments, and potential therapeutic targets presently under clinical evaluation. Recent advances in understanding the pathogenesis of liver diseases hold critical implications and translational value for the development of novel therapeutic strategies.
Read Full Literature

Correlated Market Trend: Delivery Driver

Bridging academia to market: The 60-day public search velocity mapping directly to the core technology of this paper. Dashed line represents 7-day moving average.

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

roipad.com › trend story
0%

Mayo Clinic discovers rare gene mutation that causes fatty liver disease

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability t...

crossref.org › academic paper
0%

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

No description provided.

crossref.org › academic paper
0%

Global burden of cardiovascular diseases: projections from 2025 to 2050

Abstract Aims The prediction of future trends in cardiovascular disease (CVD) mortality and their risk factors can assist policy-makers in health...

crossref.org › academic paper
0%

Proteomic signatures improve risk prediction for common and rare diseases

AbstractFor many diseases there are delays in diagnosis due to a lack of objective biomarkers for disease onset. Here, in 41,931 individuals from the United Kingdom Biobank Pharma Proteomics Projec...

crossref.org › academic paper
0%

Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options

In inflammatory bowel diseases (IBDs), such as Crohn’s disease (CD) and ulcerative colitis (UC), the immune system relentlessly attacks intestinal cells, causing recurrent tissue damage over the li...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Liver diseases: epidemiology, causes, trends and predictions'?

This literature focuses on: Abstract As a highly complex organ with digestive, endocrine, and immune-regulatory functions, the liver is pivotal in maintaining physiological homeostasis through its roles in metabolism, detoxification, and immune response. Various fa...

Which startups are commercializing the technology behind Liver diseases: epidemiology, causes, trends and predictions?

Products like Nitro by Rocketlane are bringing this to market. Their focus is: AI agents for modern service delivery.

Are there commercial applications of 'Liver diseases: epidemiology, causes, trends and predictions' in market news publications?

Yes, highly correlated activity was mapped. An entry titled 'Mayo Clinic discovers rare gene mutation that causes fatty liver disease' discusses this: Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver di...

What other academic literature is closely related to 'Liver diseases: epidemiology, causes, trends and predictions'?

Yes, highly correlated activity was mapped. An entry titled 'EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative